BIOMAT Database Logo BIOMAT Database Logo

Alterations of hemostasis associated with cardiopulmonary bypass. 1976

R L Bick, and W R Schmalhorst, and N R Arbegast

UI MeSH Term Description Entries
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D011479 Protamines A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. Protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. (From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692) Protamine,Protamine Sulfate,Protamine Chloride,Chloride, Protamine,Sulfate, Protamine
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D005112 Extracorporeal Circulation Diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation. Circulation, Extracorporeal,Circulations, Extracorporeal,Extracorporeal Circulations
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation

Related Publications

R L Bick, and W R Schmalhorst, and N R Arbegast
Alterations of hemostasis associated with cardiopulmonary bypass: pathophysiology, prevention, diagnosis, and management.
October 1976, Seminars in thrombosis and hemostasis,
R L Bick, and W R Schmalhorst, and N R Arbegast
Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass.
December 1968, The Journal of thoracic and cardiovascular surgery,
R L Bick, and W R Schmalhorst, and N R Arbegast
Alterations in host defense mechanisms associated with cardiopulmonary bypass.
January 1986, Life support systems : the journal of the European Society for Artificial Organs,
R L Bick, and W R Schmalhorst, and N R Arbegast
Hemostasis changes during cardiopulmonary bypass surgery.
July 1985, Seminars in thrombosis and hemostasis,
R L Bick, and W R Schmalhorst, and N R Arbegast
SOME VARIABLES AFFECTING HEMOSTASIS IN CARDIOPULMONARY BYPASS.
July 1964, Annals of the New York Academy of Sciences,
R L Bick, and W R Schmalhorst, and N R Arbegast
Activation of hemostasis after coronary artery bypass grafting with or without cardiopulmonary bypass.
September 2004, Anesthesia and analgesia,
R L Bick, and W R Schmalhorst, and N R Arbegast
Laboratory modalities for assessing hemostasis during cardiopulmonary bypass.
October 1976, Seminars in thrombosis and hemostasis,
R L Bick, and W R Schmalhorst, and N R Arbegast
Endotoxemia associated with cardiopulmonary bypass.
June 1987, The Journal of thoracic and cardiovascular surgery,
R L Bick, and W R Schmalhorst, and N R Arbegast
EMBOLI ASSOCIATED WITH CARDIOPULMONARY BYPASS.
August 1964, The Journal of thoracic and cardiovascular surgery,
R L Bick, and W R Schmalhorst, and N R Arbegast
Hypertension associated with cardiopulmonary bypass.
July 1984, Canadian Anaesthetists' Society journal,
Copied contents to your clipboard!